SCHEMBL6314632

SCHEMBL6314632

CC1(C(=O)O)CSC(c2c(O)ccc3ccccc23)=N1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
WDR5 P61964 1/20 0.37
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 2/20 0.37
GAA P10253 2/20 0.37
GLA P06280 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
NSD2 O96028 1/20 0.35
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
HKDC1 Q2TB90 1/20 0.35
PTPN22 Q9Y2R2 1/20 0.34
G6PD P11413 1/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
LDHA P00338 1/20 0.33
SALL4 Q9UJQ4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6989995 0.82 MEN1 (0.39) KMT2AMEN1MAPTWDR5KDM4E
SCHEMBL6315750 0.78 HTR2B (0.39) KMT2AMEN1MAPTKDM4EALDH1A1
SCHEMBL1534233 0.76 HTR2B (0.44) MAPTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL5914861 0.75 THRB (0.34) MAPTALDH1A1PIN1
SCHEMBL6315318 0.75 THRB (0.34) MAPTALDH1A1PIN1
SCHEMBL3958398 0.75 THRB (0.34) MAPTALDH1A1PIN1
SCHEMBL6314478 0.74 KDM4E (0.40) KMT2AMEN1MAPTKDM4EALDH1A1
SCHEMBL6314472 0.74 KDM4E (0.40) KMT2AMEN1MAPTKDM4EALDH1A1
SCHEMBL6321996 0.71 HTR2B (0.35) MAPTKDM4EALDH1A1GAAHPGD
SCHEMBL3305314 0.71 MAPT (0.36) MAPTALDH1A1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6894170-B2 Process for the preparation of substituted thiazolines and their intermediates DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) 2005-05-17 US disclosed
US-20050101782-A1 Process for the preparation of substituted thiazolines and their intermediates KRICH SYLVIA (AT) 2005-05-12 US disclosed
US-20030088105-A1 Process for the preparation of substituted thiazolines and their intermediates DSM FINE CHEMICALS AUSTRIA NFG GMBH & COKG (AT) 2003-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030088105-A1 Process for the preparation of substituted thiazolines and their intermediates CBR1, RCOR1, MT-CO1 KMT2A 3586/4885MEN1 773/4885MAPT 1838/4885
US-20050101782-A1 Process for the preparation of substituted thiazolines and their intermediates CBR1, CBR3, MT-CO1 KMT2A 3868/4885MEN1 488/4885MAPT 2823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.